We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRVB
1076
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$336K 0.01%
13,928
+13,553
+3,614% +$170K
CDNA icon
1077
CareDx
CDNA
$2.44B
$334K 0.01%
36,576
+35,223
+2,603% +$451K
PLTR icon
1078
Palantir
PLTR
$421B
$334K 0.01%
39,540
-6,872
-15% -$53.8K
CMC icon
1079
Commercial Metals
CMC
$8.1B
$331K 0.01%
6,761
-2,028
-23% -$105K
CPRX
1080
DELISTED
Catalyst Pharmaceutical
CPRX
$331K 0.01%
19,944
+15,442
+343% +$255K
CVBF icon
1081
CVB Financial
CVBF
$3.97B
$331K 0.01%
19,856
+19,383
+4,098% +$442K
RRC icon
1082
Range Resources
RRC
$9.41B
$331K 0.01%
12,496
-865
-6% -$21.8K
AGL icon
1083
Agilon Health
AGL
$1.63B
$330K 0.01%
556
-271
-33% -$152K
EQNR icon
1084
Equinor
EQNR
$97.4B
$330K 0.01%
11,573
+6,961
+151% +$210K
GCO icon
1085
Genesco
GCO
$419M
$330K 0.01%
8,955
+7,796
+673% +$342K
VST icon
1086
Vistra
VST
$48.2B
$330K 0.01%
13,739
-6,316
-31% -$146K
WSR
1087
DELISTED
Whitestone REIT
WSR
$329K 0.01%
35,782
+34,394
+2,478% +$333K
PRSU
1088
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
$329K 0.01%
15,792
+12,893
+445% +$321K
BRC icon
1089
Brady Corp
BRC
$4.54B
$328K 0.01%
6,109
+5,298
+653% +$277K
SIGI icon
1090
Selective Insurance
SIGI
$5.66B
$328K 0.01%
3,442
-7,419
-68% -$710K
ALLE icon
1091
Allegion
ALLE
$14.1B
$327K 0.01%
3,061
-1,621
-35% -$182K
HPQ icon
1092
HP
HPQ
$27.3B
$327K 0.01%
11,150
-7,585
-40% -$218K
SGI
1093
Somnigroup International
SGI
$13.6B
$327K 0.01%
8,282
+3,375
+69% +$134K
ESMV icon
1094
iShares ESG Optimized MSCI USA Min Vol Factor ETF
ESMV
$7.92M
$325K 0.01%
14,101
+12,441
+749% +$284K
RLI icon
1095
RLI Corp
RLI
$5.83B
$323K 0.01%
4,864
+2,430
+100% +$161K
DAVA icon
1096
Endava
DAVA
$159M
$322K 0.01%
4,796
+3,879
+423% +$305K
IMVT icon
1097
Immunovant
IMVT
$8.24B
$322K 0.01%
20,801
+17,554
+541% +$305K
ADNT icon
1098
Adient
ADNT
$1.44B
$321K 0.01%
7,842
+3,319
+73% +$139K
APA icon
1099
APA Corp
APA
$14.4B
$321K 0.01%
8,912
-7,195
-45% -$289K
DOCU
1100
DocuSign
DOCU
$11.4B
$321K 0.01%
5,505
+4,157
+308% +$248K
42 43
44
45 46

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.